Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history

The IgG antibody titer against SARS-CoV-2 receptor binding protein (RBD) after mRNA vaccine were compared between those with and without previous infection (PI) for up to 48 weeks. Though sustained higher IgG-RBD were observed in the PI group after two doses of vaccines, both groups benefited from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ota, Kenji, Murakami, Satoshi, Ishihara, Kaori, Sasaki, Daisuke, Usui, Tetsuya, Mitsumoto-Kaseida, Fujiko, Sakamoto, Kei, Kosai, Kosuke, Hasegawa, Hiroo, Takazono, Takahiro, Furumoto, Akitsugu, Asoh, Norichika, Yoshimine, Hiroyuki, Sawai, Toyomitsu, Onizuka, Masanari, Makimoto, Noriaki, Izumikawa, Koichi, Mukae, Hiroshi, Kohno, Shigeru, Yanagihara, Katsunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Short communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022459/
https://www.ncbi.nlm.nih.gov/pubmed/36960104
http://dx.doi.org/10.1016/j.jvacx.2023.100282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022459/
https://www.ncbi.nlm.nih.gov/pubmed/36960104
http://dx.doi.org/10.1016/j.jvacx.2023.100282

Ejemplares similares